BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 20432663)

  • 1. [Morphology as the starting point for individualized cancer treatment].
    Ortega JS
    An R Acad Nac Med (Madr); 2009; 126(1):127-39; discussion 140-5. PubMed ID: 20432663
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathology in the era of "Personalized Medicine": The need to learn how to integrate multivariate immunohistochemical and "omics" data with clinicopathologic information in a clinically relevant way".
    Marchevsky AM; Walts AE; Wick MR
    Ann Diagn Pathol; 2019 Dec; 43():151410. PubMed ID: 31689574
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The leading role of pathology in assessing the somatic molecular alterations of cancer: Position Paper of the European Society of Pathology.
    Matias-Guiu X; Stanta G; Carneiro F; Ryska A; Hoefler G; Moch H;
    Virchows Arch; 2020 Apr; 476(4):491-497. PubMed ID: 32124002
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Uncovering Hereditary Tumor Syndromes: Emerging Role of Surgical Pathology.
    Agaimy A; Hartmann A
    Semin Diagn Pathol; 2018 May; 35(3):154-160. PubMed ID: 29395463
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A 2015 update on predictive molecular pathology and its role in targeted cancer therapy: a review focussing on clinical relevance.
    Dietel M; Jöhrens K; Laffert MV; Hummel M; Bläker H; Pfitzner BM; Lehmann A; Denkert C; Darb-Esfahani S; Lenze D; Heppner FL; Koch A; Sers C; Klauschen F; Anagnostopoulos I
    Cancer Gene Ther; 2015 Sep; 22(9):417-30. PubMed ID: 26358176
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutation matters in precision medicine: A future to believe in.
    Dey N; Williams C; Leyland-Jones B; De P
    Cancer Treat Rev; 2017 Apr; 55():136-149. PubMed ID: 28371665
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Improvement of standardization and accuracy of medical imaging and pathological diagnosis for better diagnosis and treatment of rectal cancer].
    Yao HW; Shi XY; Chen M; Rong R; Liu YH
    Zhonghua Wei Chang Wai Ke Za Zhi; 2013 Jun; 16(6):505-8. PubMed ID: 23801198
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk Factors Associated With Circumferential Resection Margin Positivity in Rectal Cancer: A Binational Registry Study.
    Warrier SK; Kong JC; Guerra GR; Chittleborough TJ; Naik A; Ramsay RG; Lynch AC; Heriot AG
    Dis Colon Rectum; 2018 Apr; 61(4):433-440. PubMed ID: 29521824
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Morphological aspects of the hepatic response to neoadjuvant therapy.
    Fernández-Aceñero MJ; Cortés-Guiral D; Muñoz LE; Martínez-Useros J; Pastor-Idoate C
    Pathol Res Pract; 2015 Sep; 211(9):665-70. PubMed ID: 26163186
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypermutated tumours in the era of immunotherapy: The paradigm of personalised medicine.
    Nebot-Bral L; Brandao D; Verlingue L; Rouleau E; Caron O; Despras E; El-Dakdouki Y; Champiat S; Aoufouchi S; Leary A; Marabelle A; Malka D; Chaput N; Kannouche PL
    Eur J Cancer; 2017 Oct; 84():290-303. PubMed ID: 28846956
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Close/positive margins after breast-conserving therapy: additional resection or no resection?
    Wood WC
    Breast; 2013 Aug; 22 Suppl 2():S115-7. PubMed ID: 24074771
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Digital pathology in personalized cancer therapy.
    Słodkowska J; García-Rojo M
    Stud Health Technol Inform; 2012; 179():143-54. PubMed ID: 22925795
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cancer genomics and pathology: all together now.
    Shibata T
    Pathol Int; 2012 Oct; 62(10):647-59. PubMed ID: 23005591
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systematic biobanking, novel imaging techniques, and advanced molecular analysis for precise tumor diagnosis and therapy: The Polish MOBIT project.
    Niklinski J; Kretowski A; Moniuszko M; Reszec J; Michalska-Falkowska A; Niemira M; Ciborowski M; Charkiewicz R; Jurgilewicz D; Kozlowski M; Ramlau R; Piwkowski C; Kwasniewski M; Kaczmarek M; Ciereszko A; Wasniewski T; Mroz R; Naumnik W; Sierko E; Paczkowska M; Kisluk J; Sulewska A; Cybulski A; Mariak Z; Kedra B; Szamatowicz J; Kurzawa P; Minarowski L; Charkiewicz AE; Mroczko B; Malyszko J; Manegold C; Pilz L; Allgayer H; Abba ML; Juhl H; Koch F;
    Adv Med Sci; 2017 Sep; 62(2):405-413. PubMed ID: 28646744
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Application of magnetic resonance in "non-operative treatment" strategy for rectal cancer].
    Wang Y; Chen G
    Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Jun; 20(6):630-634. PubMed ID: 28643307
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of personalized biomarkers and liquid biopsies to monitor treatment response and disease recurrence in locally advanced rectal cancer after neoadjuvant chemoradiation.
    Carpinetti P; Donnard E; Bettoni F; Asprino P; Koyama F; Rozanski A; Sabbaga J; Habr-Gama A; Parmigiani RB; Galante PA; Perez RO; Camargo AA
    Oncotarget; 2015 Nov; 6(35):38360-71. PubMed ID: 26451609
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hereditary gastrointestinal carcinomas and their precursors: An algorithm for genetic testing.
    Spoto CPE; Gullo I; Carneiro F; Montgomery EA; Brosens LAA
    Semin Diagn Pathol; 2018 May; 35(3):170-183. PubMed ID: 29397239
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathology is a necessary and informative tool in oncology clinical trials.
    Nagtegaal ID; West NP; van Krieken JH; Quirke P
    J Pathol; 2014 Jan; 232(2):185-9. PubMed ID: 24037805
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High Rate of Positive Circumferential Resection Margins Following Rectal Cancer Surgery: A Call to Action.
    Rickles AS; Dietz DW; Chang GJ; Wexner SD; Berho ME; Remzi FH; Greene FL; Fleshman JW; Abbas MA; Peters W; Noyes K; Monson JR; Fleming FJ;
    Ann Surg; 2015 Dec; 262(6):891-8. PubMed ID: 26473651
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Molecular-Genetic Diagnosis and Molecular-Targeted Therapy in Cancer: Challenges in the Era of Precision Medicine].
    Miyachi H
    Rinsho Byori; 2015 Oct; 63(10):1188-93. PubMed ID: 26897855
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.